Industry says voluntary plan to curb antibiotic pollution is working, but critics want regulation

  27 January 2020

Two years into its work, a voluntary, industry-led effort to reduce pollution from antibiotic manufacturing facilities is drawing mixed reviews from outside analysts. A new report from a pharmaceutical industry group says it is making substantial progress toward curbing leaks of antibiotic compounds into the environment. But critics say the report highlights the need for governments to enact binding rules.

Studies have found that many antibiotic manufacturing facilities release the compounds they are making into the environment, often via wastewater, contributing to the deadly problem of antimicrobial resistance (AMR). (Overuse and improper disposal of drugs also contribute to AMR.)

Further reading: Science
Author(s): Natasha Gilbert
Clean Environment  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!